Janux Therapeutics, Inc. (JANX)
15.68
+0.49
(+3.23%)
USD |
NASDAQ |
Apr 17, 12:03
Janux Therapeutics Free Cash Flow : -83.28M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Bristol Myers Squibb Co. | 12.84B |
| EyePoint Plc | -243.39M |
| CorMedix, Inc. | 172.79M |
| ADMA Biologics, Inc. | 27.50M |
| Viking Therapeutics, Inc. | -278.68M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -28.54M |
| Cash from Investing (Quarterly) | 29.54M |
| Cash from Financing (Quarterly) | 2.944M |
| Free Cash Flow Per Share (Quarterly) | -0.461 |
| Free Cash Flow to Equity (Quarterly) | -28.13M |
| Free Cash Flow to Firm (Quarterly) | -28.65M |
| Free Cash Flow Yield | -8.57% |